| Date Filed | Type | Description |
| 08/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"78,341 462,175 540,516 Options Vested Unvested Total Options granted at IPO @ $18/share 334,978 334,978 669,956 Options granted March 2022 @ $9.06/share 38,017 114,051 152,068 Total Options 372,995 449,029 822,024 -2- Employee acknowledges and agrees that the foregoing Equity Summary includes an accurate and complete listing of all such equity awards, including, without limitation, all restricted shares of common stock of the Parent converted from pre-IPO limited partnership units of Parent’s predecessor , restricted stock units of the Parent and options to purchase shares of common stock of the Parent , as well as an accurate and complete breakdown of the amount of each type of equity award that has vested and the amount remaining unvested, all as of the Execution Date. For clarity, the E..." |
|
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
8-K
| Quarterly results |
| 06/09/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 9% stake in ALIGNMENT HEALTHCARE INC |
| 01/09/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 09/20/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 09/19/2022 |
424B7
| Form 424B7 - Prospectus [Rule 424(b)(7)]: |
| 09/15/2022 |
424B7
| Form 424B7 - Prospectus [Rule 424(b)(7)]: |
| 09/15/2022 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 09/06/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/04/2022 |
8-K
| Quarterly results |
| 08/03/2022 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/15/2022 |
8-K
| Quarterly results |
| 05/05/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/05/2022 |
8-K
| Quarterly results |
| 04/28/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/07/2022 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2022 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2022 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2022 |
144
| Form 144 - Report of proposed sale of securities: |
|